Literature DB >> 20407207

Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.

Ana Olivera1, Christoph Eisner, Yoshiaki Kitamura, Sandra Dillahunt, Laura Allende, Galina Tuymetova, Wendy Watford, Francoise Meylan, Susanne C Diesner, Lingli Li, Jurgen Schnermann, Richard L Proia, Juan Rivera.   

Abstract

Sphingosine kinase 1 (SphK1) and SphK2 are ubiquitous enzymes that generate sphingosine-1-phosphate (S1P), a ligand for a family of G protein-coupled receptors (S1PR1-S1PR5) with important functions in the vascular and immune systems. Here we explore the role of these kinases and receptors in recovery from anaphylaxis in mice. We found that Sphk2-/- mice had a rapid recovery from anaphylaxis. In contrast, Sphk1-/- mice showed poor recovery from anaphylaxis and delayed histamine clearance. Injection of S1P into Sphk1-/- mice increased histamine clearance and promoted recovery from anaphylaxis. Adoptive cell transfer experiments demonstrated that SphK1 activity was required in both the hematopoietic and nonhematopoietic compartments for recovery from anaphylaxis. Mice lacking the S1P receptor S1PR2 also showed a delay in plasma histamine clearance and a poor recovery from anaphylaxis. However, S1P did not promote the recovery of S1pr2-/- mice from anaphylaxis, whereas S1pr2+/- mice showed partial recovery. Unlike Sphk2-/- mice, Sphk1-/- and S1pr2-/- mice had severe hypotension during anaphylaxis. Thus, SphK1-produced S1P regulates blood pressure, histamine clearance, and recovery from anaphylaxis in a manner that involves S1PR2. This suggests that specific S1PR2 agonists may serve to counteract the vasodilation associated with anaphylactic shock.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407207      PMCID: PMC2860904          DOI: 10.1172/JCI40659

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

Review 1.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

2.  The distribution and fate of radioactive histamine in the rat.

Authors:  B N HALPERN; T NEVEU; C W WILSON
Journal:  J Physiol       Date:  1959-10       Impact factor: 5.182

3.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Sphingosine 1-phosphate analogs as receptor antagonists.

Authors:  Michael D Davis; Jeremy J Clemens; Timothy L Macdonald; Kevin R Lynch
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

5.  Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis.

Authors:  C Chrusch; S Sharma; H Unruh; E Bautista; K Duke; A Becker; W Kepron; S N Mink
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

6.  Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.

Authors:  Patrick A Singleton; Steven M Dudek; Eddie T Chiang; Joe G N Garcia
Journal:  FASEB J       Date:  2005-10       Impact factor: 5.191

7.  Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle.

Authors:  Ann M Dvorak
Journal:  Chem Immunol Allergy       Date:  2005

8.  IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses.

Authors:  Ana Olivera; Nicole Urtz; Kiyomi Mizugishi; Yumi Yamashita; Alasdair M Gilfillan; Yasuko Furumoto; Haihua Gu; Richard L Proia; Thomas Baumruker; Juan Rivera
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

9.  Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.

Authors:  Maria L Allende; Teiji Sasaki; Hiromichi Kawai; Ana Olivera; Yide Mi; Gerhild van Echten-Deckert; Richard Hajdu; Mark Rosenbach; Carol Ann Keohane; Suzanne Mandala; Sarah Spiegel; Richard L Proia
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

10.  The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering.

Authors:  E E Prieschl; R Csonga; V Novotny; G E Kikuchi; T Baumruker
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

View more
  64 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 3.  Sphingosine-1-phosphate and immune regulation: trafficking and beyond.

Authors:  Hongbo Chi
Journal:  Trends Pharmacol Sci       Date:  2010-12-14       Impact factor: 14.819

Review 4.  Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Authors:  Keisuke Yanagida; Timothy Hla
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

5.  Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia.

Authors:  Kai Singbartl; Jeffery V Bishop; Xiaoyan Wen; Raghavan Murugan; Saurabh Chandra; Marie-Dominique Filippi; John A Kellum
Journal:  Kidney Int       Date:  2011-07-06       Impact factor: 10.612

Review 6.  Targeting Sphingosine Kinases for the Treatment of Cancer.

Authors:  Clayton S Lewis; Christina Voelkel-Johnson; Charles D Smith
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 7.  S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.

Authors:  Anna Cantalupo; Annarita Di Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

8.  Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

Review 9.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

10.  Knockout of the Trpc1 gene reveals that TRPC1 can promote recovery from anaphylaxis by negatively regulating mast cell TNF-α production.

Authors:  Nevenka Medic; Avanti Desai; Ana Olivera; Joel Abramowitz; Lutz Birnbaumer; Michael A Beaven; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Cell Calcium       Date:  2013-03-13       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.